Jump to content
  • Sign Up

Archived

This topic is now archived and is closed to further replies.

Scott Adams

Alvine Pharma Secures $70M From Abbvie, Plans Large Celiac-Disease Clinical ... - Dow Jones Bankruptcy & Debt (Registration)

Recommended Posts

Alvine Pharma Secures $70M from AbbVie, Plans Large Celiac-Disease Clinical ...

Dow Jones Bankruptcy & Debt (registration)

Alvine has secured $70 million in cash from Abbott Laboratories spinoff AbbVie Inc. and granted AbbVie an option to buy its celiac-disease drug or its entire business for an undisclosed amount. The cash will enable Alvine to fund a 500-patient Phase ...

View the full article

Share this post


Link to post
Share on other sites

×
×
  • Create New...